Literature DB >> 30857393

Rigor and Reproducibility: A Systematic Review of Salivary Cortisol Sampling and Reporting Parameters Used in Cancer Survivorship Research.

Jennifer M Hulett1, Kristen L Fessele2, Margaret F Clayton3, Linda H Eaton4.   

Abstract

Salivary cortisol is a commonly used biomarker in cancer survivorship research; however, variations in sampling protocols and parameter reporting limit comparisons across studies. Standardized practices to provide rigor and reproducibility of diurnal salivary cortisol sampling and reporting are not well established. Previous systematic reviews examining relationships between diurnal salivary cortisol and clinical outcomes have resulted in mixed findings. It remains unclear which sampling protocols and reporting parameters offer the greatest utility for clinical research. This review examines diurnal salivary cortisol sampling protocols and reporting parameters to evaluate whether a standardized approach is recommended. A comprehensive search of intervention studies among adult cancer survivors including diurnal salivary cortisol resulted in 30 articles for review. Sampling protocols ranged from 1 to 4 days with the majority of studies sampling cortisol for 2 days. Sampling instances ranged from 2 to 7 times per day, with the majority collecting at 4 time points per day. Diurnal cortisol slope and cortisol awakening response (CAR) were the most commonly reported parameters associated with clinical outcomes. Flattened cortisol slopes, blunted CARs, and elevated evening cortisol concentrations were associated with poorer psychosocial and physiological outcomes. Based on our review, we propose that a rigorous, standardized diurnal salivary cortisol sampling protocol should include sampling at key diurnal times across ≥3 consecutive days to report diurnal cortisol parameters (i.e., CAR and slope) and objective measures of participant protocol adherence. Diminishing budgetary resources and efforts to minimize participant burden dictate the importance of standardized cortisol sampling protocols and reporting parameters.

Entities:  

Keywords:  best practices; cancer; cortisol measurement; review; rigor; salivary cortisol

Mesh:

Substances:

Year:  2019        PMID: 30857393      PMCID: PMC6700901          DOI: 10.1177/1099800419835321

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  45 in total

Review 1.  The awakening cortisol response: methodological issues and significance.

Authors:  A Clow; L Thorn; P Evans; F Hucklebridge
Journal:  Stress       Date:  2004-03       Impact factor: 3.493

2.  Electronic monitoring of salivary cortisol sampling compliance in daily life.

Authors:  N Jacobs; N A Nicolson; C Derom; P Delespaul; J van Os; I Myin-Germeys
Journal:  Life Sci       Date:  2005-01-26       Impact factor: 5.037

3.  Area under the curve and other summary indicators of repeated waking cortisol measurements.

Authors:  Desta B Fekedulegn; Michael E Andrew; Cecil M Burchfiel; John M Violanti; Tara A Hartley; Luenda E Charles; Diane B Miller
Journal:  Psychosom Med       Date:  2007-08-31       Impact factor: 4.312

Review 4.  Assessing salivary cortisol in large-scale, epidemiological research.

Authors:  Emma K Adam; Meena Kumari
Journal:  Psychoneuroendocrinology       Date:  2009-07-31       Impact factor: 4.905

5.  A randomized controlled trial of psychosocial interventions using the psychophysiological framework for Chinese breast cancer patients.

Authors:  Cecilia L W Chan; Rainbow T H Ho; Peter W H Lee; Josephine Y Y Cheng; Pamela P Y Leung; William Foo; Louis W H Chow; Jonathan S T Sham; David Spiegel
Journal:  J Psychosoc Oncol       Date:  2006

6.  Depression and stress reactivity in metastatic breast cancer.

Authors:  Janine Giese-Davis; Frank H Wilhelm; Ansgar Conrad; Heather C Abercrombie; Sandra Sephton; Maya Yutsis; Eric Neri; C Barr Taylor; Helena C Kraemer; David Spiegel
Journal:  Psychosom Med       Date:  2006 Sep-Oct       Impact factor: 4.312

7.  Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls.

Authors:  Linda E Carlson; Tavis S Campbell; Sheila N Garland; Paul Grossman
Journal:  J Behav Med       Date:  2007-01-24

8.  Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy.

Authors:  Linda Witek-Janusek; Sheryl Gabram; Herbert L Mathews
Journal:  Psychoneuroendocrinology       Date:  2006-11-07       Impact factor: 4.905

9.  Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer.

Authors:  Oxana Palesh; Jamie M Zeitzer; Ansgar Conrad; Janine Giese-Davis; Karen M Mustian; Varinia Popek; Karen Nga; David Spiegel
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

10.  Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.

Authors:  Susan K Lutgendorf; Aliza Z Weinrib; Frank Penedo; Daniel Russell; Koen DeGeest; Erin S Costanzo; Patrick J Henderson; Sandra E Sephton; Nicolas Rohleder; Joseph A Lucci; Steven Cole; Anil K Sood; David M Lubaroff
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

View more
  3 in total

1.  Using Graph Representation Learning to Predict Salivary Cortisol Levels in Pancreatic Cancer Patients.

Authors:  Guimin Dong; Mehdi Boukhechba; Kelly M Shaffer; Lee M Ritterband; Daniel G Gioeli; Matthew J Reilley; Tri M Le; Paul R Kunk; Todd W Bauer; Philip I Chow
Journal:  J Healthc Inform Res       Date:  2021-04-21

2.  Psychophysiological Responses in People Living with Dementia after an Art Gallery Intervention: An Exploratory Study.

Authors:  Nathan M D'Cunha; Andrew J McKune; Stephen Isbel; Jane Kellett; Ekavi N Georgousopoulou; Nenad Naumovski
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Rural-Urban Differences in Neuroimmune Biomarkers and Health Status Among Women Living With Breast Cancer.

Authors:  Jennifer M Hulett; Demetrius A Abshire; Jane M Armer; Rami Millspaugh; Joshua Millspaugh
Journal:  Cancer Nurs       Date:  2021 Jul-Aug 01       Impact factor: 2.592

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.